AnteoTech Limited

Equities

ADO

AU000000ADO8

Biotechnology & Medical Research

Market Closed - Australian S.E. 02:10:18 2024-05-24 am EDT 5-day change 1st Jan Change
0.024 AUD -4.00% Intraday chart for AnteoTech Limited +4.35% -33.33%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
AnteoTech Completes AU$1.4 Million Share Purchase Plan MT
AnteoTech Extends Closing Date of Share Purchase Plan MT
Anteotech Seeks to Raise AU$6 Million From Share Placement; Shares Fall 26% MT
AnteoTech Receives AU$1.39 Million from Queensland Critical Minerals and Battery Technology Fund; Shares Down 3% MT
AnteoTech Settles Patent Claims for AU$300,000 MT
AnteoTech Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Anteotech Completes Construction of Anteo X Production Facility in Brisbane; Shares Climb 6% MT
AnteoTech Produces Anode Material Containing Proprietary Technology MT
AnteoTech Receives AU$3.8 Million R&D Tax Rebate; Shares Rise 3% MT
AnteoTech Limited(ASX:ADO) dropped from S&P Global BMI Index CI
AnteoTech Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
AnteoTech Limited Announces Appointment of Mr. Andrew Cook as Company Secretary, Effective from 28 August 2023 CI
Anteotech Limited Announces Appointment of Mr. Andrew Cook as Chief Financial Officer CI
AnteoTech Halts Trade MT
AnteoTech Limited Announces Retirement of Christopher Parker from the Board of Directors CI
Anteotech to Undergo Major Rebranding; Shares Jump 10% MT
Anteotech Limited Announces Changes to Leadership Team CI
Anteotech Limited Announces Changes to Leadership Team CI
AnteoTech Limited(ASX:ADO) dropped from S&P/ASX Emerging Companies Index CI
AnteoTech Limited(ASX:ADO) dropped from S&P/ASX All Ordinaries Index CI
Anteotech, Wyon to Collaborate on Silicon Anodes for Micro-Batteries MT
Anteotech, Trinseo Europe Sign Deal to Develop New Product MT
AnteoTech Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
AnteoTech Appoints Chief Marketing Officer MT
AnteoTech Limited Appoints Tsui Min Lian as Chief Marketing Officer, Effective 15 March 2023 CI
Chart AnteoTech Limited
More charts
AnteoTech Limited is an Australia-based company engaged in providing solutions for the clean energy and life sciences markets using applied materials technology. The principal activities of the Company consist of development and commercialization of nanotechnologies with surface management applications. The Company’s lead product, Anteo X, provides significant improvement in anode performance and the Company partners with global suppliers in lithium-ion battery manufacturing. Its clean energy technology (CET) technologies improve the energy densities, cycle life and cost- effectiveness of lithium-ion batteries. The Company has two programs underway: Anteo X, its binder additive and the High Silicon Anode technology. The Life Sciences division services the point-of-care and in vitro diagnostics markets from global diagnostics companies to technology developers. Its AnteoBind provides advantages in bioconjugation to rapidly speed up testing procedures and improve accuracy.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ADO Stock
  4. News AnteoTech Limited
  5. AnteoTech Produces Anode Material Containing Proprietary Technology